Run-in-phase Results from a Multicenter Phase II Trial to Evaluate Pembrolizumab (P) and Gemcitabine (gem) in Patients (pts) with HER2-negative Advanced Breast Cancer (ABC): GEICAM/2015-04 PANGEA-Breast
Annals of Oncology（2018）
Key words
Combination Therapies
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined